J.B.CHEMICALS & PH (JBCHEPHARM.NS) Financials
JBCHEPHARM.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 38.0 billion | 10.8 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 35.5 billion | 10.7 billion |
JBCHEPHARM.NS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 680.6 million | ? |
| 2023-09-30 | 720.4 million | 77.0 million |
| 2023-06-30 | 627.6 million | ? |
| 2023-03-31 | 166.3 million | 166.3 million |
JBCHEPHARM.NS Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.3 billion |
| 2023-09-30 | 1.5 billion |
| 2023-06-30 | 1.4 billion |
| 2023-03-31 | 876.3 million |
JBCHEPHARM.NS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 4.5 billion | 2.9 billion | 232.7 million |
| 2023-06-30 | 2.7 billion | - | - |
| 2023-03-31 | 2.9 billion | 4.0 billion | 242.1 million |
JBCHEPHARM.NS Shares Outstanding
JBCHEPHARM.NS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 931.4 million | - | 1.5 billion | - |
| 2023-06-30 | - | - | 1.5 billion | - |
| 2023-03-31 | 7.6 billion | 319.3 million | 74.1 million | 1.8 billion |
JBCHEPHARM.NS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 8.4 billion | 2.7 billion |
| 2023-09-30 | 8.8 billion | 3.0 billion |
| 2023-06-30 | 9.0 billion | 3.1 billion |
| 2023-03-31 | 7.6 billion | -5.1 billion |
JBCHEPHARM.NS
Price: ₹1,825
Dividend Yield: 0.01%
Forward Dividend Yield: 1.21%
Payout Ratio: 67.63%
Dividend Per Share: 22.00 INR
Earnings Per Share: 32.51 INR
P/E Ratio: 54.13
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 287.6 billion
Average Dividend Frequency: 2
Years Paying Dividends: 22
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%